VICIS - Vienna Cirrhosis Study

Launched by MEDICAL UNIVERSITY OF VIENNA · Aug 28, 2017

Keywords

ClinConnect Summary

The VICIS - Vienna Cirrhosis Study is a clinical trial designed to learn more about patients with advanced chronic liver diseases, such as liver cirrhosis and related complications like portal hypertension (increased pressure in the blood vessels of the liver), fluid buildup (ascites), and liver-related confusion (hepatic encephalopathy). This study is taking place at the Vienna General Hospital and is currently recruiting participants. If you are over 18 years old and have been diagnosed with advanced liver disease, you may be eligible to join the study.

Participants in the study will have their health closely monitored through regular visits to the hospital, where important health information will be collected. This includes various lab tests and clinical assessments to help understand the condition better. Additionally, researchers will gather samples like blood, urine, and tissue from the liver and stomach to further study the disease. If you choose to participate, you will be contributing valuable information that could help improve the understanding and treatment of liver diseases for others in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age \>18 years and \<100 years
• • Diagnosis of advanced chronic liver disease (by liver stiffness ≥10kPa, HVPG\>5mmHg or Histology F3/F4)
• • Written informed consent
• Exclusion Criteria:
• • Withdrawal of written informed consent